Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
QuidelOrtho (QDEL)
NASDAQ:QDEL
Holding QDEL?
Track your performance easily
QDEL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$29.74 - $71.57
Previous CloseN/A
Volume114.08K
Average Volume (3M)939.68K
Market Cap
$2.98B
Enterprise Value$5.68B
Total Cash (Recent Filing)$169.51M
Total Debt (Recent Filing)$144.34M
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Feb 12, 2025EPS Estimate
0.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-27.89
Shares Outstanding67,256,714
10 Day Avg. Volume1,048,378
30 Day Avg. Volume939,676
Standard Deviation0.17
R-Squared0.00056
Alpha0.00584
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.06
Price to Cash Flow (P/CF)6.30
P/FCF Ratio6.50
Enterprise Value/Market Cap1.91
Enterprise Value/Revenue1.99
Enterprise Value/Gross Profit3.80
Enterprise Value/Ebitda21.38
Forecast
1Y Price Target
$51.00Price Target Upside11.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
QuidelOrtho News
PremiumCompany Announcements
QuidelOrtho Strengthens Board with Experienced Healthcare CEOs
PremiumCompany Announcements
QuidelOrtho Faces Strategic Shifts Amid Share Sale
Ownership Overview
1.38% Insiders
30.85% Mutual Funds
0.22% Other Institutional Investors
37.74% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QDEL FAQ
What was QuidelOrtho’s price range in the past 12 months?
QuidelOrtho lowest stock price was $29.73 and its highest was $71.57 in the past 12 months.
What is QuidelOrtho’s market cap?
QuidelOrtho’s market cap is $2.98B.
When is QuidelOrtho’s upcoming earnings report date?
QuidelOrtho’s upcoming earnings report date is Feb 12, 2025 which is in 13 days.
How were QuidelOrtho’s earnings last quarter?
QuidelOrtho released its earnings results on Nov 07, 2024. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.271 by $0.579.
Is QuidelOrtho overvalued?
According to Wall Street analysts QuidelOrtho’s price is currently Undervalued.
Does QuidelOrtho pay dividends?
QuidelOrtho does not currently pay dividends.
What is QuidelOrtho’s EPS estimate?
QuidelOrtho’s EPS estimate is 0.58.
How many shares outstanding does QuidelOrtho have?
QuidelOrtho has 67,256,714 shares outstanding.
What happened to QuidelOrtho’s price movement after its last earnings report?
QuidelOrtho reported an EPS of $0.85 in its last earnings report, beating expectations of $0.271. Following the earnings report the stock price went up 12.613%.
Which hedge fund is a major shareholder of QuidelOrtho?
Currently, no hedge funds are holding shares in QDEL
---
QuidelOrtho Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$51.00 (11.57% Upside)
$51.00 (11.57% Upside)
Blogger Sentiment
Bullish
QDEL Sentiment 75%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 203.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $291.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-36.79%
12-Months-Change
Fundamentals
Return on Equity
-58.57%
Trailing 12-Months
Asset Growth
-20.35%
Trailing 12-Months
Company Description
QuidelOrtho
Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.
---
QDEL Company Deck
---
QDEL Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive and negative aspects. While there are notable achievements such as strong regional growth in EMEA and Asia Pacific, successful cost-saving measures, and a stable non-respiratory business, challenges remain with revenue declines in North America and China, decreased respiratory revenue, and a decrease in gross profit margin. The reinstatement of financial guidance indicates a cautious optimism for the future.Read More>---
QDEL Stock 12 Month Forecast
Average Price Target
$51.00
▲(11.57% Upside)
Technical Analysis
Bio-Rad Laboratories
―
Hologic
―
Laboratory Corporation of America Holdings
―
Quest Diagnostics
―
Thermo Fisher
―
Best Analysts Covering QDEL
1 Year
1 Year Success Rate
9/22 ratings generated profit
1 Year Average Return
-16.78%
reiterated a buy rating 20 days ago
Copying Conor McNamara's trades and holding each position for 1 Year would result in 40.91% of your transactions generating a profit, with an average return of -16.78% per trade.
---